Exclusion included patients with a history of mood disorders or antidepressant use
If Youve Reached Your Goal Weight Instead of stopping suddenly, many people transition to a maintenance dose to prevent weight regain
Though both medications are effective in treating obesity and type 2 diabetes, tirzepatide appears to offer a slight advantage in terms of weight loss and cardiovascular improvements
Most commercial plans give 180 days, but there are exceptions: UnitedHealthcare allows just 65 days for many plan types, and Medicare Advantage plans follow CMS guidelines of 60 days
On average, the weekly dose ranges from .25mg to 2.40mg a week
Published preclinical research on FOXO4-DRI has demonstrated selective elimination of senescent cells in mouse models, with observed improvements in fitness markers, fur density, and organ function in aged subjects